The DHS Program User Forum
Discussions regarding The DHS Program data and results
Home » DHS-7 Questionnaire Review - Archived » Maternal and Child Health » postpartum hemorrhage
postpartum hemorrhage [message #1563] Thu, 13 March 2014 15:35 Go to next message
Messages: 1
Registered: March 2014
The DHS needs a question on whether the woman received oxytocin injection or misoprostol by mouth at the time of delivery.

If you need to drop a question I have my doubts about the usefulness of question 423 (did you take a drug for intestinal worms). Obviously if one is focused on anemia 423 would be important but receiving a prophylactic uterotonic to prevent postpartum hemorrhage is a major component of maternal health programs and should be collected. The other question that might be deleted would be 419 since it could be highly subject to recall bias. It would be useful to check the validity and reliability of answers to this.
Re: postpartum hemorrhage [message #1698 is a reply to message #1563] Mon, 31 March 2014 11:55 Go to previous messageGo to next message
cstanton is currently offline  cstanton
Messages: 2
Registered: March 2014
Location: New Hampshire
I couldn't agree more that we need a question on prophylactic uterotonics in the DHS - which is why we conducted a validation study of women's recall/ability to report on various aspects of intrapartum care in Mozambique (published in PLoS One and included in the PLoS MED supplement on improving the measurement of health care coverage via population-based surveys). Unfortunately, reporting on prophylactic use of uterotonics was very poor and we could not recommend its inclusion in the next round of DHS or MICS surveys, much to our disappointment. Our conclusion was that perhaps if there were a big push re: patient education so that they should expect to receive an injection immediately following birth, that reporting might improve. However, much of the oxytocin given in hospitals is given via IV and that would be even more difficult to report on. Sadly, I think data on prophylactic uterotonics will have to come from health facility-based data.

Re: postpartum hemorrhage [message #1938 is a reply to message #1698] Thu, 10 April 2014 10:29 Go to previous message
amoran is currently offline  amoran
Messages: 6
Registered: April 2014
Location: Washington DC
I also strongly agree that we need a question on prophylactic use of oxytocin to prevent PPH. However, given the results of the Mozambique validation study (PLoS One), it is not feasible to include this type of question in a household survey. I agree that we will need to work to get this information from facility-based data. However, it is important to assess the feasibility of asking about use of misoprostol tablets to prevent PPH.
Previous Topic: suggested revisions/ additions:
Next Topic: Optional Maternal Health Module
Goto Forum:

Current Time: Wed Jul 6 15:06:10 Coordinated Universal Time 2022